|
VIR-2218 and peginterferon alfa-2a Clinical Trials
1 actively recruiting trial across 1 location
Bethesda, Maryland1 trial
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
National Institutes of Health Clinical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.